surmount-1 tirzepatide weight loss percent nejm 2022 dosage chart for SURMOUNT-5 Trial - by J

Mounjaro may cause harm to the unborn child

Thighs and Buttocks: Often seen in teenagers experiencing rapid growth or individuals gaining weight

GLP-1s have been associated with rare but severe risks, including pancreatitis, gallbladder disease, bowel obstruction, stomach paralysis, acute kidney injury and vision problems

doi: 10.1056/NEJMoa2032183, 160 WilliamsE

The study found that the Pittsburgh Sleep Quality Index (PSQI) scores in the HRW group significantly decreased after the intervention compared to before the intervention, indicating a positive impact on sleep quality improvement

Milesi, Mara Mercedes, et al